Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) Accumulated Depreciation & Amortization (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Accumulated Depreciation & Amortization data on record, last reported at $56.6 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 3.67% year-over-year to $56.6 million; the TTM value through Sep 2025 reached $56.6 million, up 3.67%, while the annual FY2024 figure was $51.1 million, 261.65% up from the prior year.
  • Accumulated Depreciation & Amortization reached $56.6 million in Q3 2025 per ORGO's latest filing, up from $56.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $56.6 million in Q3 2025 and bottomed at -$76.3 million in Q2 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $20.6 million, with a median of $16.4 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 610.45% in 2023, then tumbled 1172.89% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $10.3 million in 2021, then tumbled by 126.92% to -$2.8 million in 2022, then surged by 610.45% to $14.1 million in 2023, then soared by 261.65% to $51.1 million in 2024, then increased by 10.77% to $56.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $56.6 million in Q3 2025, $56.2 million in Q2 2025, and $52.6 million in Q1 2025.